Reading this on a mobile device? Try our optimized mobile version here:

June 10, 2012
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  ADA Scientific Sessions Preview 
  • Increased public awareness could help combat diabetes' global spread
    A diabetes epidemic is unfolding around the world, with 380 million people expected to be affected by 2025, according to ADA Scientific Sessions presenter Geralyn R. Spollett, ADA President for Health Care & Education. Raising public awareness about the long-term health implications of diabetes is a priority for clinicians and educators to help combat the disease’s spread. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • National chronic disease strategy can aid diabetes prevention
    Health experts have crafted a National Prevention and Health Promotion Strategy to help promote healthy behaviors and prevent the spread of chronic diseases. The U.S. Surgeon General and a representative from the CDC will outline how this strategy can be used to prevent type 2 diabetes during an afternoon symposium today. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Experts discuss pediatric diabetes complications
    Experts examined the occurrence of diabetes-related complications -- such as hypoglycemia, eating disorders and diabetic ketoacidosis -- in pediatric patients during a Saturday symposium. Dr. Nicole Glaser of the University of California, Davis said the incidence of nonketotic hyperglycemia hyperosmolar syndrome is increasing in pediatric patients with type 1 and type 2 diabetes, which may be related to a continuum of disease with diabetic ketoacidosis. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Annual Norbert Freinkel lecture to focus on embryopathy
    The relationship between hyperglycemia and embryopathy is the subject of this year's Norbert Freinkel Award Lecture. Presenters will focus on advances in the study of the relationship between diabetes and fetal cellular dysfunctions and birth defects, as well as potential therapeutic interventions. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Symposium looks at efficacy of lifestyle changes, metformin in prediabetes
    The prescription of lifestyle changes and metformin to treat patients at risk of developing type 2 diabetes can be effective when followed up by trained professionals as part of a lifestyle program, according to data presented as part of the symposium "The Role of Pharmacology in Managing Prediabetes." However, other experts argue that lifestyle changes and metformin may lack long-term efficacy. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Studies highlight importance of genetics in diabetes
    Efforts to transform genome-wide area studies, or GWAS, to clinical utility are increasingly important in light of evidence showing genetic factors can improve the prediction of type 2 diabetes compared with clinical factors alone. Studies in Finland and Sweden have shown a family history of diabetes is a bigger risk factor than any single clinical marker. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Research looks at role of brown fat in obesity
    Understanding the role that brown fat plays in burning calories may give practitioners better insight into obesity and insulin resistance. Research shows the amount of brown fat an individual carries is in inverse proportion with obesity and that the amount also decreases with age. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Incretin-based therapy options considered in symposium
    Agents within the classes of DPP-4 inhibitors and GLP-1 receptor agonists have comparable therapeutic effects for type 2 diabetes, although some pharmacodynamic and pharmacokinetic differences have been observed. Presenters at the symposium "Incretin-Based Therapies" examined the options available on the market and the data resulting from their application. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Experts look at effect of statins on diabetes risks
    Research around the possible side effects associated with the use of statins and the role such treatments can play in the onset of diabetes is a key part of the symposium "Hot Topics in Diabetes, Dyslipimedia, and Cardiovascular Disease." Data suggest an increased, dose-dependent diabetes risk with the use of statins. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Symposium tracks efforts to promote beta cell genesis
    Researchers are using small molecules to advance the promise of cellular therapy and the artificial pancreas to treat diabetes. The symposium "Discovery of Molecules for Beta Cell Genesis" explores different methods under development to promote beta cell creation, regeneration and survival. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
Support DiabetesPro SmartBrief
DiabetesPro SmartBrief is the daily e-news resource for 29,000 influential leaders in diabetes care. E-mail Aaron Kern for more information on advertising.

  Conference Information 
  • Poster Hall
    Posters will be displayed continuously today and Monday. Poster presenters will be available for discussion at their posters during one of two General Poster Sessions, scheduled from noon to 2 p.m. today and Monday. All Late Breaking Posters, regardless of category, will be presented today during the General Poster Session. Refer to the Final Program for the complete General Poster Session schedule. LinkedInFacebookTwitterEmail this Story
  • Guided Audio Poster Tours
    Explore the Poster Hall with a Guided Audio Poster Tour. Moderators will lead attendees on one-hour tours, sharing their perspectives and highlighting novel or recent developments in question-and-answer sessions with poster presenters. LinkedInFacebookTwitterEmail this Story
  • Abstracts on CD
    The Scientific Sessions Abstracts on CD contains searchable electronic copies of all abstracts from the 72nd Scientific Sessions. This compact and easily portable format provides enduring access to abstracts. Visit the Sanofi Exhibit in Booth 201 to pick up your copy.
    Sponsored by Sanofi
    LinkedInFacebookTwitterEmail this Story
  • Meeting updates and highlights
    The 72nd Scientific Sessions website will include a page listing program updates and changes as they happen. The page will also include daily meeting highlights and events. Learn more. LinkedInFacebookTwitterEmail this Story
  • Get the 72nd Scientific Sessions App!
    Planning your time at the Scientific Sessions is only a click away with the on-the-go Scientific Sessions App! This application gives direct and instant access to meeting information from your smartphone, tablet or other handheld device. Features include interactive program and course schedules, customizable calendar and itinerary builder, exhibitor listing with interactive booth map, social media interaction and special meeting alerts. Learn more. LinkedInFacebookTwitterEmail this Story
  • Diabetes Dispatch Newspaper
    Read the full newspaper of the 72nd Scientific Sessions to learn about what's happening at the meeting this year. Read it now. LinkedInFacebookTwitterEmail this Story

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual American Diabetes Association endorsements. The news reported in SmartBrief does not necessarily reflect the official position of American Diabetes Association.
Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information